Senseonics Holdings, Inc. (AMEX:SENS) will be discussing 2Q20 financial results with the investment community.on 10th August 2020 at 4:30 PM eastern time.
Those interested in listening to the conference call live via the Internet can visit www.senseonics.com
Earnings Expectation
Senseonics Holdings, Inc. is set to announce second quarter earning results on Monday 10th August 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, SENS to report 2Q20 loss of $ 0.09 per share from revenue of $ 1.43 million. For the full year, analysts anticipate top line of $ 8.12 million, while looking forward to loss of $ 0.42 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 15.00 million ~ $ 20.00 million
Click Here For More Historical Outlooks Of Senseonics Holdings, Inc.
Senseonics Holdings, Inc., a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days. The company has a collaboration agreement Roche Diabetes Care, Inc.
